SILVER SPRING, MD & RESEARCH TRIANGLE PARK, NC – United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced the addition of former Minnesota Commissioner of Health Jan Malcolm to its Board of… Read More
Neuroscientist John McDonald, archaeological scientist Michael Richards and computational chemist Samira Siahrostami’s appointments were announced June 14 by the federal government. These scholars advance Canadian research excellence in a range… Read More
Renowned, experienced industry leader in newly created role for Cytiva Ruffieux joins Cytiva executive team on 1 July 2024 Cytiva is strengthening its leadership team with one of the biotechnology… Read More
Celsius’ CEL383 is a potential first-in-class anti-Triggering Receptor Expressed on Myeloid Cells 1 (TREM1) antibody for the treatment of inflammatory bowel disease (IBD) NORTH CHICAGO, IL – AbbVie (NYSE: ABBV) announced… Read More
SOUTH SAN FRANCISCO, CA – Abdera Therapeutics Inc., a biopharmaceutical company leveraging its advanced antibody engineering ROVEr™ platform to design and develop tunable, precision radiopharmaceuticals for cancer, announced that the… Read More
